[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
KCR Cap posts on X about $gmed, $xrays, $zimv, $aif the most. They currently have XXX followers and XX posts still getting attention that total XX engagements in the last XX hours.
Social category influence stocks
Social topic influence $gmed, $xrays, $zimv, $aif, $csgp, $64mm, $1mm, $10mm, doubled, $xray
Top assets mentioned GLOBUS MEDICAL INC (GMED) CoStar Group, Inc. (CSGP) DENTSPLY SIRONA Inc (XRAY)
Top posts by engagements in the last XX hours
"So Scavilla gets the value of his unvested GMED options assuming an ATH share price + the upside of $XRAY's stock if he can engineer a turnaround. And he doubles his annual comp. Not a bad financial decision" @KcrCap on X 2025-07-21 14:51:32 UTC XXX followers, XX engagements
"$ZIMV a commoditized business with flat/declining revs was acquired for 10.5x EBITDA today. $GMED deserves a significant premium to ZIMV but using this as a floor valuation suggests +30% upside from current price. Again GMED is growing and comps suggest a multiple b/w 12-14x" @KcrCap on X 2025-07-21 14:51:33 UTC XXX followers, XXX engagements
"I can't find anything that corroborates these stats from the $CSGP Q2 call but if they are accurate this is very good news for $AIF CN" @KcrCap on X 2025-07-23 18:23:14 UTC XXX followers, XXX engagements
"$GMED CEO resignation is surprising but looks like Scavilla was paid handsomely to take over $XRAY. Annual comp doubled to $10mm + $1mm signing bonus + $6.4mm initial stock grant (which coincidentally = the value of his unvested GMED options at $XX or GMED's ATH share price)" @KcrCap on X 2025-07-21 14:51:32 UTC XXX followers, XXX engagements
"$GMED's Q2 results announced in conjunction with CEO transition show that business fundamentals are back on track after a disappointing Q1" @KcrCap on X 2025-07-21 14:51:32 UTC XXX followers, XXX engagements